LITS
Lite Strategy, Inc.
Price Chart
Latest Quote
$1.16
+0.04 (+3.57%)
Current Price
| Previous Close | $1.12 |
| Open | $1.15 |
| Day High | $1.17 |
| Day Low | $1.11 |
| Volume | 61,959 |
Stock Information
| Shares Outstanding | 30.41M |
| Cash Equivalents | $5.71M |
| Net Income | $-71.15M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $35.12M |
| EPS (TTM) | $-2.06 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $29.41M |
| Income | $-71.15M |
| Book/sh | $1.28 |
| Cash/sh | $0.19 |
| Employees | 5 |
Financial Ratios
| Quick Ratio | 5.34 |
| Current Ratio | 5.75 |
Returns & Margins
| ROA | -24.74% |
| ROE | -243.02% |
Ownership
| Insider Ownership | 1.38% |
| Institutional Ownership | 19.36% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| PEG | 2.22 |
| P/B | 0.90 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $nan |
| SMA50 | $nan |
| SMA200 | $nan |
| RSI | 34.69 |
| ATR | nan |
| Shares Float | 28.21M |
| Short Float | 0.62% |
| Short Ratio | 0.21 |
| Volatility | 0.01 |
| Rel Volume | 0.26 |
Performance History
| Week | nan% |
| Month | nan% |
| Quarter | nan% |
| 6 Months | nan% |
| YTD | nan% |
| Year | nan% |
| 3 Years | nan% |
| 5 Years | nan% |
| 10 Years | nan% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $nan | 105,044 |
| 2026-10-26 | $1.12 | 163,500 |
| 2026-10-23 | $1.16 | 141,100 |
| 2026-10-22 | $1.19 | 169,000 |
| 2026-10-21 | $1.24 | 164,200 |
| 2026-10-20 | $1.19 | 223,500 |
| 2026-10-19 | $1.16 | 190,800 |
| 2026-10-16 | $1.15 | 115,700 |
| 2026-10-15 | $1.20 | 317,900 |
| 2026-10-14 | $1.17 | 278,700 |
| 2026-10-13 | $1.21 | 294,300 |
| 2026-10-12 | $1.22 | 271,300 |
| 2026-10-09 | $1.27 | 539,900 |
| 2026-10-08 | $1.22 | 982,800 |
| 2026-10-07 | $1.27 | 786,800 |
| 2026-10-06 | $1.41 | 493,800 |
| 2026-10-05 | $1.40 | 432,500 |
| 2026-10-02 | $1.38 | 1,008,000 |
| 2026-10-01 | $1.38 | 1,036,800 |
| 2026-09-30 | $1.32 | 329,000 |
| 2026-09-29 | $1.38 | 627,200 |
| 2026-09-28 | $1.36 | 951,000 |
About Lite Strategy, Inc.
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. It is also involved in holding Litecoin tokens as a primary reserve asset. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
đ° Latest News
No news articles available at the moment. Check back later for updates on LITS.
Period:
Loading...
Income Statement (Annual)
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $65,297,000 | $48,816,000 |
| Operating Revenue | $0 | $0 | $65,297,000 | $48,816,000 |
| Reconciled Cost Of Revenue | - | - | - | - |
| Cost Of Revenue | - | - | - | - |
| Expenses | ||||
| Total Expenses | $12,169,000 | $17,455,000 | $39,856,000 | $85,580,000 |
| Other Income Expense | $-59,248,000 | $484,000 | $-10,940,000 | $1,581,000 |
| Net Non Operating Interest Income Expense | $267,000 | $1,026,000 | $3,277,000 | $3,345,000 |
| Operating Expense | $12,169,000 | $17,455,000 | $39,856,000 | $85,580,000 |
| General And Administrative Expense | $12,047,000 | $13,532,000 | $23,295,000 | $33,130,000 |
| Other Non Operating Income Expenses | - | $-16,000 | $-41,000 | $-22,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-71,150,000 | $-15,945,000 | $17,778,000 | $-31,838,000 |
| Net Interest Income | $267,000 | $1,026,000 | $3,277,000 | $3,345,000 |
| Interest Income | $267,000 | $1,026,000 | $3,277,000 | $3,345,000 |
| Normalized Income | $-11,902,000 | $-16,445,000 | $25,883,586 | $-33,441,000 |
| Net Income From Continuing And Discontinued Operation | $-71,150,000 | $-15,945,000 | $17,778,000 | $-31,838,000 |
| Total Operating Income As Reported | $-66,577,000 | $-17,455,000 | $14,542,000 | $-36,764,000 |
| Net Income Common Stockholders | $-71,150,000 | $-15,945,000 | $17,778,000 | $-31,838,000 |
| Net Income | $-71,150,000 | $-15,945,000 | $17,778,000 | $-31,838,000 |
| Net Income Including Noncontrolling Interests | $-71,150,000 | $-15,945,000 | $17,778,000 | $-31,838,000 |
| Net Income Continuous Operations | $-71,150,000 | $-15,945,000 | $17,778,000 | $-31,838,000 |
| Pretax Income | $-71,150,000 | $-15,945,000 | $17,778,000 | $-31,838,000 |
| Special Income Charges | $0 | $500,000 | $-10,899,000 | $0 |
| Interest Income Non Operating | $267,000 | $1,026,000 | $3,277,000 | $3,345,000 |
| Operating Income | $-12,169,000 | $-17,455,000 | $25,441,000 | $-36,764,000 |
| Average Dilution Earnings | - | - | - | $0 |
| Gross Profit | - | - | - | - |
| Per Share | ||||
| Diluted EPS | - | $-2.39 | $2.67 | $-4.78 |
| Basic EPS | - | $-2.39 | $2.67 | $-4.78 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $-2,793,414 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $47,079,000 | $-17,587,000 | $36,723,000 | $-37,981,000 |
| Total Unusual Items | $-59,248,000 | $500,000 | $-10,899,000 | $1,603,000 |
| Total Unusual Items Excluding Goodwill | $-59,248,000 | $500,000 | $-10,899,000 | $1,603,000 |
| Reconciled Depreciation | $0 | $368,000 | $383,000 | $386,000 |
| EBITDA (Bullshit earnings) | $-12,169,000 | $-17,087,000 | $25,824,000 | $-36,378,000 |
| EBIT | $-12,169,000 | $-17,455,000 | $25,441,000 | $-36,764,000 |
| Diluted NI Availto Com Stockholders | $-71,150,000 | $-15,945,000 | $17,778,000 | $-31,838,000 |
| Gain On Sale Of Ppe | $0 | $500,000 | $0 | - |
| Gain On Sale Of Security | $-59,248,000 | - | - | $1,603,000 |
| Research And Development | $122,000 | $3,923,000 | $16,561,000 | $52,450,000 |
| Selling General And Administration | $12,047,000 | $13,532,000 | $23,295,000 | $33,130,000 |
| Other Gand A | $12,047,000 | $13,532,000 | $23,295,000 | $33,130,000 |
| Diluted Average Shares | - | $6,663,000 | $6,663,000 | $6,663,000 |
| Basic Average Shares | - | $6,663,000 | $6,663,000 | $6,663,000 |
| Impairment Of Capital Assets | - | $0 | $10,899,000 | $0 |
| Tax Provision | - | - | - | - |
Fetched: 2026-10-27
Balance Sheet (Annual)
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $41,623,000 | $16,931,000 | $33,020,000 | $24,624,000 |
| Total Assets | $42,692,000 | $18,285,000 | $41,375,000 | $120,809,000 |
| Total Non Current Assets | $36,551,000 | $0 | $606,000 | $13,281,000 |
| Other Non Current Assets | $652,000 | - | - | - |
| Non Current Accounts Receivable | $7,627,000 | - | - | - |
| Financial Assets | $1,000,000 | $0 | - | - |
| Investmentin Financial Assets | $27,272,000 | $0 | - | - |
| Current Assets | $6,141,000 | $18,285,000 | $40,769,000 | $107,528,000 |
| Other Current Assets | $435,000 | $274,000 | $1,374,000 | $2,151,000 |
| Cash Cash Equivalents And Short Term Investments | $5,706,000 | $18,011,000 | $38,345,000 | $100,693,000 |
| Cash And Cash Equivalents | $5,706,000 | $18,011,000 | $3,705,000 | $16,906,000 |
| Prepaid Assets | - | $0 | $1,050,000 | $4,599,000 |
| Receivables | - | - | $0 | $85,000 |
| Other Receivables | - | - | - | $85,000 |
| Accounts Receivable | - | - | - | $0 |
| Goodwill And Other Intangible Assets | - | - | - | - |
| Taxes Receivable | - | - | - | - |
| Debt | ||||
| Total Debt | - | - | $0 | $12,728,000 |
| Long Term Debt And Capital Lease Obligation | - | - | $0 | $11,300,000 |
| Current Debt And Capital Lease Obligation | - | - | - | $1,428,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,069,000 | $1,354,000 | $8,355,000 | $96,185,000 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $0 | $75,845,000 |
| Current Liabilities | $1,069,000 | $1,354,000 | $8,355,000 | $20,340,000 |
| Other Current Liabilities | $40,000 | - | - | - |
| Payables And Accrued Expenses | $373,000 | $481,000 | $5,534,000 | $11,406,000 |
| Payables | $261,000 | $176,000 | $3,168,000 | $6,134,000 |
| Accounts Payable | $261,000 | $176,000 | $3,168,000 | $6,134,000 |
| Non Current Deferred Liabilities | - | - | $0 | $64,545,000 |
| Current Deferred Liabilities | - | - | $0 | $317,000 |
| Derivative Product Liabilities | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $41,623,000 | $16,931,000 | $33,020,000 | $24,624,000 |
| Total Equity Gross Minority Interest | $41,623,000 | $16,931,000 | $33,020,000 | $24,624,000 |
| Stockholders Equity | $41,623,000 | $16,931,000 | $33,020,000 | $24,624,000 |
| Retained Earnings | $-475,314,000 | $-404,164,000 | $-388,219,000 | $-405,997,000 |
| Other | ||||
| Preferred Shares Number | $1,000 | $1,000 | $1,000 | $1,000 |
| Ordinary Shares Number | $32,407,000 | $6,662,857 | $6,662,857 | $6,663,000 |
| Share Issued | $32,407,000 | $6,662,857 | $6,662,857 | $6,663,000 |
| Tangible Book Value | $41,623,000 | $16,931,000 | $33,020,000 | $24,624,000 |
| Invested Capital | $41,623,000 | $16,931,000 | $33,020,000 | $24,624,000 |
| Working Capital | $5,072,000 | $16,931,000 | $32,414,000 | $87,188,000 |
| Total Capitalization | $41,623,000 | $16,931,000 | $33,020,000 | $24,624,000 |
| Treasury Stock | $4,895,000 | $0 | - | - |
| Additional Paid In Capital | $521,832,000 | $421,095,000 | $421,239,000 | $430,621,000 |
| Capital Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Pensionand Other Post Retirement Benefit Plans Current | $656,000 | $873,000 | $2,821,000 | $7,189,000 |
| Current Accrued Expenses | $112,000 | $305,000 | $2,366,000 | $5,272,000 |
| Investments And Advances | $27,272,000 | $0 | - | - |
| Available For Sale Securities | $27,272,000 | - | - | - |
| Net PPE | - | $0 | $606,000 | $13,281,000 |
| Gross PPE | - | $0 | $2,370,000 | $14,315,000 |
| Buildings And Improvements | - | $0 | $214,000 | $11,972,000 |
| Properties | - | $0 | $0 | $0 |
| Other Short Term Investments | - | $0 | $34,640,000 | $83,787,000 |
| Capital Lease Obligations | - | - | $0 | $12,728,000 |
| Non Current Deferred Revenue | - | - | $0 | $64,545,000 |
| Long Term Capital Lease Obligation | - | - | $0 | $11,300,000 |
| Current Deferred Revenue | - | - | $0 | $317,000 |
| Current Capital Lease Obligation | - | - | $0 | $1,428,000 |
| Accumulated Depreciation | - | - | $-1,764,000 | $-1,034,000 |
| Leases | - | - | $969,000 | $969,000 |
| Other Properties | - | - | $187,000 | $374,000 |
| Machinery Furniture Equipment | - | - | $1,000,000 | $1,000,000 |
Fetched: 2026-10-27
Cash Flow Statement (Annual)
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-9,121,000 | $-20,844,000 | $-50,480,000 | $-52,519,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-9,121,000 | $-20,844,000 | $-50,473,000 | $-52,484,000 |
| Cash Flow From Continuing Operating Activities | $-9,121,000 | $-20,844,000 | $-50,473,000 | $-52,484,000 |
| Operating Gains Losses | $-813,000 | $-486,000 | $32,000 | $-1,103,000 |
| Investing Activities | ||||
| Investing Cash Flow | $-95,107,000 | $35,150,000 | $49,140,000 | $53,690,000 |
| Cash Flow From Continuing Investing Activities | $-95,107,000 | $35,150,000 | $49,140,000 | $53,690,000 |
| Capital Expenditure | - | - | $-7,000 | $-35,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-4,895,000 | $0 | - | - |
| Issuance Of Capital Stock | $96,818,000 | $0 | - | $0 |
| Financing Cash Flow | $91,923,000 | $0 | $-11,868,000 | $-40,000 |
| Cash Flow From Continuing Financing Activities | $91,923,000 | $0 | $-11,868,000 | $-40,000 |
| Net Common Stock Issuance | $91,923,000 | $0 | - | $0 |
| Common Stock Issuance | $96,818,000 | $0 | - | $0 |
| Cash Dividends Paid | - | $0 | $-11,660,000 | $0 |
| Common Stock Dividend Paid | - | $0 | $-11,660,000 | $0 |
| Net Other Financing Charges | - | - | $-208,000 | $-40,000 |
| Other | ||||
| End Cash Position | $5,706,000 | $18,011,000 | $3,705,000 | $16,906,000 |
| Beginning Cash Position | $18,011,000 | $3,705,000 | $16,906,000 | $15,740,000 |
| Changes In Cash | $-12,305,000 | $14,306,000 | $-13,201,000 | $1,166,000 |
| Common Stock Payments | $-4,895,000 | $0 | - | - |
| Net Investment Purchase And Sale | $-100,147,000 | $35,140,000 | $49,147,000 | $53,725,000 |
| Sale Of Investment | $853,000 | $35,140,000 | $107,379,000 | $155,489,000 |
| Purchase Of Investment | $-101,000,000 | $0 | $-58,232,000 | $-101,764,000 |
| Net Intangibles Purchase And Sale | $5,040,000 | $0 | - | - |
| Sale Of Intangibles | $5,040,000 | $0 | - | - |
| Net PPE Purchase And Sale | $0 | $10,000 | $-7,000 | $-35,000 |
| Sale Of PPE | $0 | $10,000 | $0 | - |
| Change In Working Capital | $-1,028,000 | $-4,851,000 | $-84,276,000 | $-24,947,000 |
| Change In Other Current Assets | $-652,000 | $0 | - | - |
| Change In Payables And Accrued Expense | $-325,000 | $-7,001,000 | $-10,421,000 | $-143,000 |
| Change In Accrued Expense | $-410,000 | $-4,009,000 | $-7,274,000 | $1,641,000 |
| Change In Payable | $85,000 | $-2,992,000 | $-3,147,000 | $-1,784,000 |
| Change In Account Payable | $85,000 | $-2,992,000 | $-3,147,000 | $-1,784,000 |
| Change In Prepaid Assets | $-51,000 | $2,150,000 | $4,534,000 | $-2,920,000 |
| Other Non Cash Items | $2,521,000 | $214,000 | $2,433,000 | $1,429,000 |
| Stock Based Compensation | $1,288,000 | $-144,000 | $2,278,000 | $3,589,000 |
| Unrealized Gain Loss On Investment Securities | $60,061,000 | $0 | - | - |
| Depreciation Amortization Depletion | $0 | $368,000 | $383,000 | $386,000 |
| Depreciation And Amortization | $0 | $368,000 | $383,000 | $386,000 |
| Depreciation | $0 | $368,000 | $383,000 | $386,000 |
| Gain Loss On Investment Securities | $-813,000 | $-500,000 | - | $-1,103,000 |
| Gain Loss On Sale Of PPE | $0 | $14,000 | $32,000 | $0 |
| Net Income From Continuing Operations | $-71,150,000 | $-15,945,000 | $17,778,000 | $-31,838,000 |
| Purchase Of PPE | - | $0 | $-7,000 | $-35,000 |
| Change In Other Current Liabilities | - | $0 | $-13,612,000 | $-1,261,000 |
| Change In Receivables | - | $0 | $85,000 | $9,959,000 |
| Asset Impairment Charge | - | $0 | $10,899,000 | $0 |
| Change In Other Working Capital | - | - | $-64,862,000 | $-30,582,000 |
| Proceeds From Stock Option Exercised | - | - | - | $0 |
| Income Tax Paid Supplemental Data | - | - | - | - |
Fetched: 2026-10-27